Bio-Rad Laboratories, Inc. BIO.B Clinical Diagnostics — Cost of goods sold

Other segment segments

Similar metrics at other companies

TEMDiagnostics — Cost of Goods Sold

$100.96M+19.1%

TEC

TECHDiagnostics And Spatial Biology — Cost of Goods Sold

$38.65M+3.9%

RVTYDiagnostics — Segment Cost of Revenue

$156.75M+16.0%

GEHCPDx — Cost of Sales

$406M+38.1%

LHDiagnostics — Supplies Expense

$613.5M+4.6%

LHClinicaldiagnosticslaboratory — Net Revenue

$1.79B+8.7%

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s clinical diagnostics — cost of goods sold?

Bio-Rad Laboratories, Inc. (BIO.B) reported clinical diagnostics — cost of goods sold of $181.8M in Q1 2026.

How has Bio-Rad Laboratories, Inc.'s clinical diagnostics — cost of goods sold changed year-over-year?

Bio-Rad Laboratories, Inc.'s clinical diagnostics — cost of goods sold increased by 1.5% year-over-year, from $179.2M to $181.8M.

What is the long-term trend for Bio-Rad Laboratories, Inc.'s clinical diagnostics — cost of goods sold?

Over 3 years (2022 to 2025), Bio-Rad Laboratories, Inc.'s clinical diagnostics — cost of goods sold has grown at a 3.6% compound annual growth rate (CAGR), from $696.5M to $775.3M.

What does clinical diagnostics — cost of goods sold mean?

The direct costs incurred to manufacture and sell diagnostic products.

How do you interpret clinical diagnostics — cost of goods sold?

Lower costs relative to sales indicate improved manufacturing efficiency or favorable product mix.

How does clinical diagnostics — cost of goods sold compare across companies?

Used to calculate gross margin; peers in diagnostics typically maintain consistent cost structures.